Alto Neuroscience Stock Quote ANRO - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

14.22

Bid

Ask

Volume

114,893

13.87 Day's Range 14.64

12.7798 52 Week Range 24.00

Market Cap

380.207M

Previous Close

14.40

Open

14.36

Last Trade

2085

14.22

Last Trade Time

Financial Volume

$ 1,629,127

VWAP

14.1795

Average Volume (3m)

200,115

Shares Outstanding

26,794,000

Dividend Yield

PE Ratio

-10.47

Earnings Per Share (EPS)

-1.36

Revenue

Net Profit

-36.31M

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ b... Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.altoneuroscience.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alto Neuroscience Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker ANRO. The last closing price for Alto Neuroscience was $14.40. Over the last year, Alto Neuroscience shares have traded in a share price range of $ 12.7798 to $ 24.00.

Alto Neuroscience currently has 26,794,000 shares outstanding. The market capitalization of Alto Neuroscience is $380.21 million. Alto Neuroscience has a price to earnings ratio (PE ratio) of -10.47.

Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia

– ALTO-101 demonstrated a favorable pharmacokinetic and tolerability profile; novel transdermal formulation delivered significantly greater drug exposure and fewer adverse events typically...

Alto Neuroscience Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the closing of its previously announced upsized initial public offering of 9,246,000 shares of common stock, which includes the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.28	2.00860832138	13.94	16.535	13.87	73925	15.40677936	CS
4	0.3	2.15517241379	13.92	16.535	12.7798	87667	14.14143883	CS
12	-4.38	-23.5483870968	18.6	19	12.7798	200115	14.87422683	CS
26	-7.78	-35.3636363636	22	24	12.7798	233413	15.98323309	CS
52	-7.78	-35.3636363636	22	24	12.7798	233413	15.98323309	CS
156	-7.78	-35.3636363636	22	24	12.7798	233413	15.98323309	CS
260	-7.78	-35.3636363636	22	24	12.7798	233413	15.98323309	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 6.8001 (254.17%)	31.01M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.17M
SHOTWSafety Shot Inc	$ 0.45 (45.16%)	644
AIPArteris Inc	$ 8.185 (38.03%)	1.11M
RGFReal Good Food Company Inc	$ 0.85 (37.32%)	4.26M
MNDRMobile health Network Solutions	$ 3.33 (-84.91%)	18.76M
NUVOHoldco Nuvo Group DG Ltd	$ 2.00 (-57.54%)	1.04M
SPTSprout Social Inc	$ 28.82 (-40.15%)	13.47M
UNITUniti Group Inc	$ 4.441 (-26.35%)	21.07M
IPDNProfessional Diversity Network Inc	$ 1.29 (-24.12%)	659.97k
AAPLApple Inc	$ 183.38 (5.98%)	163.22M
SQQQProShares UltraPro Short QQQ	$ 11.08 (-5.94%)	154.59M
JAGXJaguar Health Inc	$ 0.3164 (7.91%)	142.41M
NKLANikola Corporation	$ 0.6526 (6.55%)	106.88M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.17M